115 related articles for article (PubMed ID: 11870805)
1. Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communities.
Kubota Y; Ito K; Imai K; Yamanaka H
Prostate; 2002 Mar; 50(4):262-9. PubMed ID: 11870805
[TBL] [Abstract][Full Text] [Related]
2. [Prostate tumor and its diagnosis].
Yamanaka H
Rinsho Byori; 2001 Jul; 49(7):633-7. PubMed ID: 11519121
[TBL] [Abstract][Full Text] [Related]
3. Mass screening for prostate cancer and the bias relating to survival rate.
Imai K; Suzuki T; Yamanaka H; Nakata S; Tomaru Y; Sato J; Kato N
Urol Int; 1993; 51(3):133-41. PubMed ID: 8249223
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of prostate cancer mortality in a Finnish randomized screening trial.
Neupane S; Steyerberg E; Raitanen J; Talala K; Pylväläinen J; Taari K; Tammela TL; Auvinen A
Int J Urol; 2018 Mar; 25(3):270-276. PubMed ID: 29224236
[TBL] [Abstract][Full Text] [Related]
5. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
[TBL] [Abstract][Full Text] [Related]
6. [Mass screening for prostate cancer at Ikeda City in Osaka Prefecture--results of screening with PSA alone between 2003 and 2007].
Inoue H; Kinouchi T; Kinoshita T; Kobayashi M; Ued T; Takada T; Hara T; Yamaguchi S; Kajimoto M; Kitamura K
Nihon Hinyokika Gakkai Zasshi; 2010 Jul; 101(5):671-5. PubMed ID: 20715498
[TBL] [Abstract][Full Text] [Related]
7. The correlation of stage and pathology of prostate cancer in Japan.
Kubota Y; Imai K; Yamanaka H
Int J Urol; 2000 Apr; 7(4):139-44. PubMed ID: 10810970
[TBL] [Abstract][Full Text] [Related]
8. [The significance of early detection for prostate cancer in mass screening].
Kato M; Tammbo M; Yoshimatsu T; Ohta M; Kinjyo M; Noda H; Watanabe K; Miyata A; Murata A; Miura I; Yoneda T; Yoshii M; Okegawa T; Kojima M; Sayama T; Nutahara K; Higashihara E
Nihon Hinyokika Gakkai Zasshi; 2001 Jan; 92(1):23-9. PubMed ID: 11235139
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer.
Ito K; Yamamoto T; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
Urology; 2000 Aug; 56(2):278-82. PubMed ID: 10925094
[TBL] [Abstract][Full Text] [Related]
10. Lead time of prostate cancer detected in population based screening for prostate cancer in Japan.
Ito K; Yamamoto T; Miyakubo M; Takechi H; Ohi M; Shibata Y; Suzuki K
J Urol; 2007 Oct; 178(4 Pt 1):1258-63; discussion 1263-4. PubMed ID: 17698107
[TBL] [Abstract][Full Text] [Related]
11. Interval carcinomas in the European Randomized Study of Screening for Prostate Cancer (ERSPC)-Rotterdam.
van der Cruijsen-Koeter IW; van der Kwast TH; Schröder FH
J Natl Cancer Inst; 2003 Oct; 95(19):1462-6. PubMed ID: 14519752
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.
Candas B; Cusan L; Gomez JL; Diamond P; Suburu RE; Lévesque J; Brousseau G; Bélanger A; Labrie F
Prostate; 2000 Sep; 45(1):19-35. PubMed ID: 10960839
[TBL] [Abstract][Full Text] [Related]
13. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
[TBL] [Abstract][Full Text] [Related]
14. [Prostate cancer screening at Tatebayashi City in Gunma prefecture--results of screening with PSA alone between 2003 and 2005].
Nakamura T; Etsunaga T; Sasaki Y; Nitta T; Okugi Y; Okazaki H; Katou N; Yamamoto T; Suzuki K
Nihon Hinyokika Gakkai Zasshi; 2007 May; 98(4):619-28. PubMed ID: 17564105
[TBL] [Abstract][Full Text] [Related]
15. [The mass screening for prostate cancer and the age eligibility. Gunma Urological Oncology Study Group].
Imai K; Suzuki T; Kumasaka H; Kurosawa I; Kurihara J; Machida M; Makino T; Kiren H; Sato J; Yamanaka H
Nihon Hinyokika Gakkai Zasshi; 1996 Oct; 87(10):1191-6. PubMed ID: 8937115
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan.
Takechi H; Ito K; Yamamoto T; Miyakubo M; Ohi M; Suzuki K
Urology; 2008 Nov; 72(5):1111-5. PubMed ID: 18342926
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of prostate specific antigen for early stage prostate cancer detection.
Imai K; Ichinose Y; Kubota Y; Yamanaka H; Sato J; Saitoh M; Watanabe H; Ohe H
Jpn J Clin Oncol; 1994 Jun; 24(3):160-5. PubMed ID: 7516445
[TBL] [Abstract][Full Text] [Related]
18. [The result of mass screening of 1997 for prostatic cancer in Isesaki City].
Kobayashi M; Takezawa Y; Nakata S; Inoue M; Kurihara H; Kondo T; Kosaku N; Matsumoto K; Nakazato H; Yamanaka H
Nihon Hinyokika Gakkai Zasshi; 2000 Jan; 91(1):1-7. PubMed ID: 10689876
[TBL] [Abstract][Full Text] [Related]
19. [Clinical research on prostate cancer detected in Tone central hospital--comparison of survival rates between patients diagnosed with prostate cancer in and outside screening system].
Tamur Y; Koya T; Morita T; Kubota Y; Takahashi O; Fujiduka I; Ito K; Suzuki K
Nihon Hinyokika Gakkai Zasshi; 2009 May; 100(4):525-33. PubMed ID: 19514274
[TBL] [Abstract][Full Text] [Related]
20. [Mass screening for prostate cancer in Tokushima City: the results of 2001].
Kanayama HO; Kagawa S; Utsunomiya M; Kawashima S; Takehisa I; Sumitani H; Yokozeki H
Nihon Hinyokika Gakkai Zasshi; 2004 Mar; 95(3):596-603. PubMed ID: 15103922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
